Over two million receive nucleic acid tests in Beijing
BEIJING — Beijing conducted nucleic acid tests on more than 2.34 million people from June 12 to 21, the municipal health authorities said on June 23.
Zhang Hua, deputy director of Beijing Municipal Health Commission, said at a news conference on June 23 that, during the peak period, a total of 2,422 sample collection points were set up at 480 venues across the capital for nucleic acid testing.
More than 7,400 personnel from hospitals, community health service centers, third-party testing agencies, and disease prevention and control departments have participated in sample collection during the tests.
The daily nucleic acid testing capacity of Beijing has now increased from 40,000 to more than 300,000 samples. If batch testing is employed, the capital can test over 1 million people per day, according to Zhang.
Hundreds of thousands of medical staff, public security officers, community workers, volunteers, and government officials have joined in the massive testing campaigns. These campaigns play an important role in screening, isolating, and treating infected patients, as well as stemming the spread of COVID-19 in Beijing.
Beijing reported 13 newly confirmed, domestically-transmitted COVID-19 cases, two suspected cases, and one asymptomatic case on June 22, the municipal health commission said on June 23.
From June 11 to 22, Beijing reported 249 confirmed domestically-transmitted cases, all of whom were receiving treatment in hospitals.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


